6 Dimensions Capital

Nan Li built his career at the intersection of computer science and life sciences, partnering with technical founders building platforms generating proprietary biological datasets and infrastructure for computational drug discovery.

Wei Li is a founding board member at Sirius Therapeutics, Inc. and has investment experience across medical devices, drug discovery tools and services, and therapeutic products. Li has worked as a venture professional in healthcare and life sciences.

Hannes Smarason is a Venture Partner at 6 Dimensions Capital and Co-Founder and Senior Advisor to WuXi NextCODE, a Contract Genomics Organization focused on applying sequence data to diagnostics and precision medicine. He previously served as CEO of WuXi NextCODE, overseeing its operations across the U.S., China, and Iceland, and as CFO and Executive Vice President of Business and Finance at deCODE from 1997 to 2004, where he contributed to the company's development as a leader in human genome analysis and its subsequent $415 million acquisition by Amgen. Smarason also served as Chairman and CEO of Icelandair and held prior positions at McKinsey & Company and as an advisor to venture investors including Polaris Venture Partners and ARCH Venture Partners.

Hao Zhang serves as Director of Business Development at Curon Biopharmaceutical. He brings seven years of research experience in biochemistry, molecular biology, animal modeling, and mathematical modeling, along with a track record of scientific publications and conference presentations. His technical expertise spans both experimental laboratory work and computational approaches, including quantitative modeling, big data analysis, and computer-assisted drug development.

Mo Zhao is an equity analyst at Orbis Investments focused on biopharma investing. He holds scientific expertise and business education relevant to the sector.

Norman Chen is the Chief Executive Officer of The Asian American Foundation, bringing over thirty years of experience in entrepreneurship, healthcare, and community leadership across the United States and Asia. He previously co-founded the nonprofit Leading Asian Americans to Unite for Change and contributed to the STAATUS Index research on American attitudes toward Asian Americans. His background includes founding Asia Renal Care, a specialty medical network operating across six countries, co-founding DeltaHealth Hospital in partnership with Columbia Heartsource, and leading life sciences investments at Fidelity Asia Ventures and 6 Dimensions Capital. Chen holds a B.S. from MIT and an MBA from Stanford Graduate School of Business, and serves on boards and advisory councils for organizations including The Nature Conservancy, Children's Medical Foundation, and SF Marine Science Institute.